Cargando…
Antitumor effects of pharmacological EZH2 inhibition on malignant peripheral nerve sheath tumor through the miR-30a and KPNB1 pathway
BACKGROUND: Enhancer of zeste homolog 2 (EZH2) is a key epigenetic regulator in cancer cell survival, epithelial-mesenchymal transition, and tumorigenesis. Inhibition of EZH2 has become a promising therapeutic option for various human malignancies. Previously, we demonstrated that the EZH2/miR-30d/k...
Autores principales: | Zhang, Pingyu, Yang, Xianbin, Ma, Xiaoyan, Ingram, Davis R, Lazar, Alexander J, Torres, Keila E, Pollock, Raphael E |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4357176/ https://www.ncbi.nlm.nih.gov/pubmed/25890085 http://dx.doi.org/10.1186/s12943-015-0325-1 |
Ejemplares similares
-
AXL Inhibition Enhances MEK Inhibitor Sensitivity in Malignant Peripheral Nerve Sheath Tumors
por: Landers, Sharon M., et al.
Publicado: (2020) -
KPNB1 mediates PER/CRY nuclear translocation and circadian clock function
por: Lee, Yool, et al.
Publicado: (2015) -
Expression and inhibition of BRD4, EZH2 and TOP2A in neurofibromas and malignant peripheral nerve sheath tumors
por: Amirnasr, Azadeh, et al.
Publicado: (2017) -
HDAC8, A Potential Therapeutic Target for the Treatment of Malignant Peripheral Nerve Sheath Tumors (MPNST)
por: Lopez, Gonzalo, et al.
Publicado: (2015) -
Decreased KPNB1 Expression is Induced by PLK1 Inhibition and Leads to Apoptosis in Lung Adenocarcinoma
por: Sekimoto, Noboru, et al.
Publicado: (2017)